The efficacy and safety of lenvatinib for advanced hepatocellular carcinoma in a real-world setting View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2019-01-22

AUTHORS

Shuntaro Obi, Takahisa Sato, Shinpei Sato, Miho Kanda, Yuta Tokudome, Yuichiro Kojima, Yoji Suzuki, Kenji Hosoda, Toshihiro Kawai, Yuji Kondo, Yoshihiro Isomura, Hiroshi Ohyama, Keiko Nakagomi, Hiroshi Ashizawa, Yuko Miura, Hiroyuki Amano, Hitoshi Mochizuki, Masao Omata

ABSTRACT

Background/purposeLenvatinib (an inhibitor of vascular endothelial growth factor (GF) receptors 1–3, fibroblast GF receptors 1–4, platelet-derived GF receptor α, rearranged during transfection, and stem cell factor receptor) was non-inferior to sorafenib in a phase 3 (REFLECT) trial of advanced hepatocellular carcinoma. This study examined the efficacy and safety of lenvatinib in a real-world setting.MethodsThis was a retrospective, multicenter, observational study. Inclusion and exclusion criteria were based on the phase 3 trial, and participants were observed for at least 12 weeks. Therapeutic effect was determined using the modified Response Evaluation Criteria In Solid Tumors (m-RECIST) at the 8th week. Patients received oral lenvatinib 12 mg/day (body weight > 60 kg) or 8 mg/day (body weight < 60 kg). Dose interruptions followed by reductions for lenvatinib-related toxicities were permitted. Grades of adverse events (AEs) complied with the Common Terminology Criteria for Adverse Events version 4.0.ResultsAll 16 patients included in this study had prior treatment history, and a median 3.9 years had passed since the first treatment. Fatigue, hypertension, and proteinuria were the most frequent AEs, and were higher than Grade 2. AEs could be controlled by appropriate dose reduction, interruption, and symptomatic treatment according to the protocol. In the m-RECIST evaluation at the 8th week, 0, 6, 8, and 1 patients had achieved complete response, partial response, stable disease, and progressive disease, respectively. The objective response rate was 40%.ConclusionLenvatinib treatment could be accomplished with safety and good response in a real-world setting. More... »

PAGES

199-204

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s12072-019-09929-4

DOI

http://dx.doi.org/10.1007/s12072-019-09929-4

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1111602329

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30671808


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Hepatocellular", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fatigue", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hypertension", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Liver Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Phenylurea Compounds", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proteinuria", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Quinolines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Response Evaluation Criteria in Solid Tumors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Gastroenterology and Hepatology, Kyoundo Hospital of Sasaki Institute, 1-8 Kandasurugadai, Chiyoda, 101-0062, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.419521.a", 
          "name": [
            "Internal Medicine, Chiba General Medical Center, Teikyo University, 3426-3 Anesaki, 299-0111, Ichihara, Chiba, Japan", 
            "Department of Gastroenterology, Yamanashi Prefectural Central Hospital, 1-1-1 Fujimi, 400-8506, Kofu, Yamanashi, Japan", 
            "Department of Gastroenterology and Hepatology, Kyoundo Hospital of Sasaki Institute, 1-8 Kandasurugadai, Chiyoda, 101-0062, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Obi", 
        "givenName": "Shuntaro", 
        "id": "sg:person.01254432457.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01254432457.23"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Internal Medicine, Chiba General Medical Center, Teikyo University, 3426-3 Anesaki, 299-0111, Ichihara, Chiba, Japan", 
          "id": "http://www.grid.ac/institutes/grid.264706.1", 
          "name": [
            "Internal Medicine, Chiba General Medical Center, Teikyo University, 3426-3 Anesaki, 299-0111, Ichihara, Chiba, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sato", 
        "givenName": "Takahisa", 
        "id": "sg:person.0667017261.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0667017261.48"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Gastroenterology and Hepatology, Kyoundo Hospital of Sasaki Institute, 1-8 Kandasurugadai, Chiyoda, 101-0062, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.419521.a", 
          "name": [
            "Internal Medicine, Chiba General Medical Center, Teikyo University, 3426-3 Anesaki, 299-0111, Ichihara, Chiba, Japan", 
            "Department of Gastroenterology and Hepatology, Kyoundo Hospital of Sasaki Institute, 1-8 Kandasurugadai, Chiyoda, 101-0062, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sato", 
        "givenName": "Shinpei", 
        "id": "sg:person.011676455302.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011676455302.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Gastroenterology and Hepatology, Kyoundo Hospital of Sasaki Institute, 1-8 Kandasurugadai, Chiyoda, 101-0062, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.419521.a", 
          "name": [
            "Department of Gastroenterology, Yamanashi Prefectural Central Hospital, 1-1-1 Fujimi, 400-8506, Kofu, Yamanashi, Japan", 
            "Department of Gastroenterology and Hepatology, Kyoundo Hospital of Sasaki Institute, 1-8 Kandasurugadai, Chiyoda, 101-0062, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kanda", 
        "givenName": "Miho", 
        "id": "sg:person.0774752554.50", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0774752554.50"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pharmacy, Kyoundo Hospital of Sasaki Institute, 1-8 Kandasurugadai, Chiyoda, 101-0062, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.419521.a", 
          "name": [
            "Department of Pharmacy, Kyoundo Hospital of Sasaki Institute, 1-8 Kandasurugadai, Chiyoda, 101-0062, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tokudome", 
        "givenName": "Yuta", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Gastroenterology, Yamanashi Prefectural Central Hospital, 1-1-1 Fujimi, 400-8506, Kofu, Yamanashi, Japan", 
          "id": "http://www.grid.ac/institutes/grid.417333.1", 
          "name": [
            "Department of Gastroenterology, Yamanashi Prefectural Central Hospital, 1-1-1 Fujimi, 400-8506, Kofu, Yamanashi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kojima", 
        "givenName": "Yuichiro", 
        "id": "sg:person.01177703152.96", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01177703152.96"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Gastroenterology, Yamanashi Prefectural Central Hospital, 1-1-1 Fujimi, 400-8506, Kofu, Yamanashi, Japan", 
          "id": "http://www.grid.ac/institutes/grid.417333.1", 
          "name": [
            "Department of Gastroenterology, Yamanashi Prefectural Central Hospital, 1-1-1 Fujimi, 400-8506, Kofu, Yamanashi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Suzuki", 
        "givenName": "Yoji", 
        "id": "sg:person.015073732504.68", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015073732504.68"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Gastroenterology, Yamanashi Prefectural Central Hospital, 1-1-1 Fujimi, 400-8506, Kofu, Yamanashi, Japan", 
          "id": "http://www.grid.ac/institutes/grid.417333.1", 
          "name": [
            "Department of Gastroenterology, Yamanashi Prefectural Central Hospital, 1-1-1 Fujimi, 400-8506, Kofu, Yamanashi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hosoda", 
        "givenName": "Kenji", 
        "id": "sg:person.0632777552.91", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0632777552.91"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Gastroenterology and Hepatology, Kyoundo Hospital of Sasaki Institute, 1-8 Kandasurugadai, Chiyoda, 101-0062, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.419521.a", 
          "name": [
            "Internal Medicine, Chiba General Medical Center, Teikyo University, 3426-3 Anesaki, 299-0111, Ichihara, Chiba, Japan", 
            "Department of Gastroenterology and Hepatology, Kyoundo Hospital of Sasaki Institute, 1-8 Kandasurugadai, Chiyoda, 101-0062, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kawai", 
        "givenName": "Toshihiro", 
        "id": "sg:person.0705653172.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0705653172.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Gastroenterology and Hepatology, Kyoundo Hospital of Sasaki Institute, 1-8 Kandasurugadai, Chiyoda, 101-0062, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.419521.a", 
          "name": [
            "Department of Gastroenterology and Hepatology, Kyoundo Hospital of Sasaki Institute, 1-8 Kandasurugadai, Chiyoda, 101-0062, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kondo", 
        "givenName": "Yuji", 
        "id": "sg:person.01207264125.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01207264125.06"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Gastroenterology and Hepatology, Kyoundo Hospital of Sasaki Institute, 1-8 Kandasurugadai, Chiyoda, 101-0062, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.419521.a", 
          "name": [
            "Department of Gastroenterology and Hepatology, Kyoundo Hospital of Sasaki Institute, 1-8 Kandasurugadai, Chiyoda, 101-0062, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Isomura", 
        "givenName": "Yoshihiro", 
        "id": "sg:person.0760341765.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0760341765.13"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Gastroenterology, Yamanashi Prefectural Central Hospital, 1-1-1 Fujimi, 400-8506, Kofu, Yamanashi, Japan", 
          "id": "http://www.grid.ac/institutes/grid.417333.1", 
          "name": [
            "Department of Gastroenterology, Yamanashi Prefectural Central Hospital, 1-1-1 Fujimi, 400-8506, Kofu, Yamanashi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ohyama", 
        "givenName": "Hiroshi", 
        "id": "sg:person.01176700500.71", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01176700500.71"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Gastroenterology, Yamanashi Prefectural Central Hospital, 1-1-1 Fujimi, 400-8506, Kofu, Yamanashi, Japan", 
          "id": "http://www.grid.ac/institutes/grid.417333.1", 
          "name": [
            "Department of Gastroenterology, Yamanashi Prefectural Central Hospital, 1-1-1 Fujimi, 400-8506, Kofu, Yamanashi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nakagomi", 
        "givenName": "Keiko", 
        "id": "sg:person.015046073654.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015046073654.54"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Gastroenterology, Yamanashi Prefectural Central Hospital, 1-1-1 Fujimi, 400-8506, Kofu, Yamanashi, Japan", 
          "id": "http://www.grid.ac/institutes/grid.417333.1", 
          "name": [
            "Department of Gastroenterology, Yamanashi Prefectural Central Hospital, 1-1-1 Fujimi, 400-8506, Kofu, Yamanashi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ashizawa", 
        "givenName": "Hiroshi", 
        "id": "sg:person.014250513254.95", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014250513254.95"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Gastroenterology, Yamanashi Prefectural Central Hospital, 1-1-1 Fujimi, 400-8506, Kofu, Yamanashi, Japan", 
          "id": "http://www.grid.ac/institutes/grid.417333.1", 
          "name": [
            "Department of Gastroenterology, Yamanashi Prefectural Central Hospital, 1-1-1 Fujimi, 400-8506, Kofu, Yamanashi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Miura", 
        "givenName": "Yuko", 
        "id": "sg:person.015131416123.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015131416123.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Gastroenterology, Yamanashi Prefectural Central Hospital, 1-1-1 Fujimi, 400-8506, Kofu, Yamanashi, Japan", 
          "id": "http://www.grid.ac/institutes/grid.417333.1", 
          "name": [
            "Department of Gastroenterology, Yamanashi Prefectural Central Hospital, 1-1-1 Fujimi, 400-8506, Kofu, Yamanashi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Amano", 
        "givenName": "Hiroyuki", 
        "id": "sg:person.016524357123.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016524357123.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Gastroenterology, Yamanashi Prefectural Central Hospital, 1-1-1 Fujimi, 400-8506, Kofu, Yamanashi, Japan", 
          "id": "http://www.grid.ac/institutes/grid.417333.1", 
          "name": [
            "Department of Gastroenterology, Yamanashi Prefectural Central Hospital, 1-1-1 Fujimi, 400-8506, Kofu, Yamanashi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mochizuki", 
        "givenName": "Hitoshi", 
        "id": "sg:person.01335140136.50", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01335140136.50"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Gastroenterology, Tokyo University, 7-3-1 Hongo, Bunkyo, 113-8655, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "Department of Gastroenterology, Yamanashi Prefectural Central Hospital, 1-1-1 Fujimi, 400-8506, Kofu, Yamanashi, Japan", 
            "Department of Gastroenterology, Tokyo University, 7-3-1 Hongo, Bunkyo, 113-8655, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Omata", 
        "givenName": "Masao", 
        "id": "sg:person.0775700471.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0775700471.08"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s12072-017-9799-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1086045643", 
          "https://doi.org/10.1007/s12072-017-9799-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00535-016-1263-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022330529", 
          "https://doi.org/10.1007/s00535-016-1263-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.2012.154", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031103423", 
          "https://doi.org/10.1038/bjc.2012.154"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-01-22", 
    "datePublishedReg": "2019-01-22", 
    "description": "Background/purposeLenvatinib (an inhibitor of vascular endothelial growth factor (GF) receptors 1\u20133, fibroblast GF receptors 1\u20134, platelet-derived GF receptor \u03b1, rearranged during transfection, and stem cell factor receptor) was non-inferior to sorafenib in a phase 3 (REFLECT) trial of advanced hepatocellular carcinoma. This study examined the efficacy and safety of lenvatinib in a real-world setting.MethodsThis was a retrospective, multicenter, observational study. Inclusion and exclusion criteria were based on the phase 3 trial, and participants were observed for at least 12\u00a0weeks. Therapeutic effect was determined using the modified Response Evaluation Criteria In Solid Tumors (m-RECIST) at the 8th week. Patients received oral lenvatinib 12\u00a0mg/day (body weight\u2009>\u200960\u00a0kg) or 8\u00a0mg/day (body weight\u2009<\u200960\u00a0kg). Dose interruptions followed by reductions for lenvatinib-related toxicities were permitted. Grades of adverse events (AEs) complied with the Common Terminology Criteria for Adverse Events version 4.0.ResultsAll 16 patients included in this study had prior treatment history, and a median 3.9\u00a0years had passed since the first treatment. Fatigue, hypertension, and proteinuria were the most frequent AEs, and were higher than Grade 2. AEs could be controlled by appropriate dose reduction, interruption, and symptomatic treatment according to the protocol. In the m-RECIST evaluation at the 8th week, 0, 6, 8, and 1 patients had achieved complete response, partial response, stable disease, and progressive disease, respectively. The objective response rate was 40%.ConclusionLenvatinib treatment could be accomplished with safety and good response in a real-world setting.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s12072-019-09929-4", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1038556", 
        "issn": [
          "1936-0533", 
          "1936-0541"
        ], 
        "name": "Hepatology International", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "13"
      }
    ], 
    "keywords": [
      "safety of lenvatinib", 
      "phase 3 trial", 
      "advanced hepatocellular carcinoma", 
      "adverse events", 
      "real-world setting", 
      "hepatocellular carcinoma", 
      "objective response rate", 
      "Common Terminology Criteria", 
      "frequent adverse events", 
      "Response Evaluation Criteria", 
      "appropriate dose reduction", 
      "prior treatment history", 
      "RECIST evaluation", 
      "dose interruption", 
      "Terminology Criteria", 
      "stable disease", 
      "progressive disease", 
      "complete response", 
      "partial response", 
      "symptomatic treatment", 
      "therapeutic effect", 
      "observational study", 
      "exclusion criteria", 
      "dose reduction", 
      "treatment history", 
      "grade 2", 
      "solid tumors", 
      "first treatment", 
      "response rate", 
      "lenvatinib", 
      "patients", 
      "weeks", 
      "good response", 
      "carcinoma", 
      "treatment", 
      "disease", 
      "trials", 
      "efficacy", 
      "safety", 
      "days", 
      "setting", 
      "multicenter", 
      "hypertension", 
      "proteinuria", 
      "response", 
      "MethodsThis", 
      "tumors", 
      "criteria", 
      "study", 
      "interruption", 
      "toxicity", 
      "reduction", 
      "participants", 
      "grade", 
      "evaluation criteria", 
      "years", 
      "fatigue", 
      "history", 
      "evaluation", 
      "protocol", 
      "rate", 
      "events", 
      "effect", 
      "inclusion", 
      "Background/purposeLenvatinib", 
      "purposeLenvatinib", 
      "oral lenvatinib 12", 
      "lenvatinib 12", 
      "ConclusionLenvatinib treatment"
    ], 
    "name": "The efficacy and safety of lenvatinib for advanced hepatocellular carcinoma in a real-world setting", 
    "pagination": "199-204", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1111602329"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s12072-019-09929-4"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30671808"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s12072-019-09929-4", 
      "https://app.dimensions.ai/details/publication/pub.1111602329"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-12-01T19:45", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_812.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s12072-019-09929-4"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s12072-019-09929-4'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s12072-019-09929-4'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s12072-019-09929-4'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s12072-019-09929-4'


 

This table displays all metadata directly associated to this object as RDF triples.

343 TRIPLES      22 PREDICATES      115 URIs      104 LITERALS      24 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s12072-019-09929-4 schema:about N003451f5f78846e79e3d17777dcc431d
2 N011d1d26023144c5ac3643506786ca99
3 N2c4c83893948487fa46b894ec1a00d26
4 N35ae76619fe24154bf52936e84e8f4be
5 N3f190ccdeabd40b9bd16a52bea008023
6 N451b98db3a0f428e82751b2ee7a9f5e6
7 N4c9b3062b9e544e0a0d212fbafacee6c
8 N74687ffe933d468ea85ba77452823386
9 N761d22c063b34c938b44c723a2ec6cc2
10 N9885654d536343d0b603abb48bff5d18
11 Nb1b697f891924978ba44b933b7e3dbd4
12 Nb7dc44838c564b3e9b1e23b113b79890
13 Nbc87b700358043e1a5ebe9aa5ecccdae
14 Nbd22118a08214c1bba02acfd39a0907e
15 Nca7b960b33aa4c87a903fe2142c77372
16 Ncfdac9585d344b1b84087a37e09e7f97
17 Necb9a178682640f29d8d26ea610a8eb7
18 anzsrc-for:11
19 anzsrc-for:1103
20 schema:author N4ca2777c709d4c849d6a9deeb5077c5e
21 schema:citation sg:pub.10.1007/s00535-016-1263-4
22 sg:pub.10.1007/s12072-017-9799-9
23 sg:pub.10.1038/bjc.2012.154
24 schema:datePublished 2019-01-22
25 schema:datePublishedReg 2019-01-22
26 schema:description Background/purposeLenvatinib (an inhibitor of vascular endothelial growth factor (GF) receptors 1–3, fibroblast GF receptors 1–4, platelet-derived GF receptor α, rearranged during transfection, and stem cell factor receptor) was non-inferior to sorafenib in a phase 3 (REFLECT) trial of advanced hepatocellular carcinoma. This study examined the efficacy and safety of lenvatinib in a real-world setting.MethodsThis was a retrospective, multicenter, observational study. Inclusion and exclusion criteria were based on the phase 3 trial, and participants were observed for at least 12 weeks. Therapeutic effect was determined using the modified Response Evaluation Criteria In Solid Tumors (m-RECIST) at the 8th week. Patients received oral lenvatinib 12 mg/day (body weight > 60 kg) or 8 mg/day (body weight < 60 kg). Dose interruptions followed by reductions for lenvatinib-related toxicities were permitted. Grades of adverse events (AEs) complied with the Common Terminology Criteria for Adverse Events version 4.0.ResultsAll 16 patients included in this study had prior treatment history, and a median 3.9 years had passed since the first treatment. Fatigue, hypertension, and proteinuria were the most frequent AEs, and were higher than Grade 2. AEs could be controlled by appropriate dose reduction, interruption, and symptomatic treatment according to the protocol. In the m-RECIST evaluation at the 8th week, 0, 6, 8, and 1 patients had achieved complete response, partial response, stable disease, and progressive disease, respectively. The objective response rate was 40%.ConclusionLenvatinib treatment could be accomplished with safety and good response in a real-world setting.
27 schema:genre article
28 schema:inLanguage en
29 schema:isAccessibleForFree false
30 schema:isPartOf N862dc607ab14474784c1d64902e2fb1f
31 Na8c22d72a2d74d6096372701532dbd86
32 sg:journal.1038556
33 schema:keywords Background/purposeLenvatinib
34 Common Terminology Criteria
35 ConclusionLenvatinib treatment
36 MethodsThis
37 RECIST evaluation
38 Response Evaluation Criteria
39 Terminology Criteria
40 advanced hepatocellular carcinoma
41 adverse events
42 appropriate dose reduction
43 carcinoma
44 complete response
45 criteria
46 days
47 disease
48 dose interruption
49 dose reduction
50 effect
51 efficacy
52 evaluation
53 evaluation criteria
54 events
55 exclusion criteria
56 fatigue
57 first treatment
58 frequent adverse events
59 good response
60 grade
61 grade 2
62 hepatocellular carcinoma
63 history
64 hypertension
65 inclusion
66 interruption
67 lenvatinib
68 lenvatinib 12
69 multicenter
70 objective response rate
71 observational study
72 oral lenvatinib 12
73 partial response
74 participants
75 patients
76 phase 3 trial
77 prior treatment history
78 progressive disease
79 proteinuria
80 protocol
81 purposeLenvatinib
82 rate
83 real-world setting
84 reduction
85 response
86 response rate
87 safety
88 safety of lenvatinib
89 setting
90 solid tumors
91 stable disease
92 study
93 symptomatic treatment
94 therapeutic effect
95 toxicity
96 treatment
97 treatment history
98 trials
99 tumors
100 weeks
101 years
102 schema:name The efficacy and safety of lenvatinib for advanced hepatocellular carcinoma in a real-world setting
103 schema:pagination 199-204
104 schema:productId N100ed28342f444d9aaf050a117a73d11
105 Na6fadd6c9b594c7cb39ffbab7225d8ef
106 Ne6e74a090fd242129b5c8180dd7242fb
107 schema:sameAs https://app.dimensions.ai/details/publication/pub.1111602329
108 https://doi.org/10.1007/s12072-019-09929-4
109 schema:sdDatePublished 2021-12-01T19:45
110 schema:sdLicense https://scigraph.springernature.com/explorer/license/
111 schema:sdPublisher N4616338c55234721a33b8634673f23e3
112 schema:url https://doi.org/10.1007/s12072-019-09929-4
113 sgo:license sg:explorer/license/
114 sgo:sdDataset articles
115 rdf:type schema:ScholarlyArticle
116 N003451f5f78846e79e3d17777dcc431d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Humans
118 rdf:type schema:DefinedTerm
119 N011d1d26023144c5ac3643506786ca99 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Middle Aged
121 rdf:type schema:DefinedTerm
122 N100ed28342f444d9aaf050a117a73d11 schema:name dimensions_id
123 schema:value pub.1111602329
124 rdf:type schema:PropertyValue
125 N18221f491ee243c9883fed084278c6d8 rdf:first sg:person.015073732504.68
126 rdf:rest N52e53b23c2384f559d9d1edc6bdb59bf
127 N1cf68605ac0b406fafffda5c338f2289 rdf:first sg:person.0760341765.13
128 rdf:rest Nbbb8a2be59ac49dd9e3e975638fa7bbc
129 N20aae0026be145a9882b9f390e116821 rdf:first sg:person.014250513254.95
130 rdf:rest Nbbe99124103f4e23b329a39ed81222f9
131 N2a8bf00631ba4634b754bffc1bb32edc rdf:first sg:person.0774752554.50
132 rdf:rest N7aaf91935c274e28b7d6957165a39320
133 N2c4c83893948487fa46b894ec1a00d26 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Retrospective Studies
135 rdf:type schema:DefinedTerm
136 N35ae76619fe24154bf52936e84e8f4be schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Fatigue
138 rdf:type schema:DefinedTerm
139 N3704eed88d5f465eaff68e971811d95c schema:affiliation grid-institutes:grid.419521.a
140 schema:familyName Tokudome
141 schema:givenName Yuta
142 rdf:type schema:Person
143 N3f190ccdeabd40b9bd16a52bea008023 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Antineoplastic Agents
145 rdf:type schema:DefinedTerm
146 N413c57bc442847b48a9c89fc7ecf5f08 rdf:first sg:person.0705653172.09
147 rdf:rest N5fa0de578a5446c980596885e421b3f3
148 N451b98db3a0f428e82751b2ee7a9f5e6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Aged, 80 and over
150 rdf:type schema:DefinedTerm
151 N4616338c55234721a33b8634673f23e3 schema:name Springer Nature - SN SciGraph project
152 rdf:type schema:Organization
153 N4c9b3062b9e544e0a0d212fbafacee6c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Liver Neoplasms
155 rdf:type schema:DefinedTerm
156 N4ca2777c709d4c849d6a9deeb5077c5e rdf:first sg:person.01254432457.23
157 rdf:rest Nffc49964e6904c8db5820e02646e5df8
158 N52e53b23c2384f559d9d1edc6bdb59bf rdf:first sg:person.0632777552.91
159 rdf:rest N413c57bc442847b48a9c89fc7ecf5f08
160 N59f53eb48e5e461090bf00d73dcd9628 rdf:first sg:person.015046073654.54
161 rdf:rest N20aae0026be145a9882b9f390e116821
162 N5fa0de578a5446c980596885e421b3f3 rdf:first sg:person.01207264125.06
163 rdf:rest N1cf68605ac0b406fafffda5c338f2289
164 N68220c9aee07404da2cf36c54253b387 rdf:first sg:person.01177703152.96
165 rdf:rest N18221f491ee243c9883fed084278c6d8
166 N74687ffe933d468ea85ba77452823386 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Response Evaluation Criteria in Solid Tumors
168 rdf:type schema:DefinedTerm
169 N761d22c063b34c938b44c723a2ec6cc2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Treatment Outcome
171 rdf:type schema:DefinedTerm
172 N7aaf91935c274e28b7d6957165a39320 rdf:first N3704eed88d5f465eaff68e971811d95c
173 rdf:rest N68220c9aee07404da2cf36c54253b387
174 N862dc607ab14474784c1d64902e2fb1f schema:volumeNumber 13
175 rdf:type schema:PublicationVolume
176 N9885654d536343d0b603abb48bff5d18 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Hypertension
178 rdf:type schema:DefinedTerm
179 Na6fadd6c9b594c7cb39ffbab7225d8ef schema:name pubmed_id
180 schema:value 30671808
181 rdf:type schema:PropertyValue
182 Na74642850fb14b4fbb33c70d60753342 rdf:first sg:person.011676455302.10
183 rdf:rest N2a8bf00631ba4634b754bffc1bb32edc
184 Na8c22d72a2d74d6096372701532dbd86 schema:issueNumber 2
185 rdf:type schema:PublicationIssue
186 Nb1b697f891924978ba44b933b7e3dbd4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
187 schema:name Aged
188 rdf:type schema:DefinedTerm
189 Nb7dc44838c564b3e9b1e23b113b79890 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
190 schema:name Male
191 rdf:type schema:DefinedTerm
192 Nbbb8a2be59ac49dd9e3e975638fa7bbc rdf:first sg:person.01176700500.71
193 rdf:rest N59f53eb48e5e461090bf00d73dcd9628
194 Nbbe99124103f4e23b329a39ed81222f9 rdf:first sg:person.015131416123.15
195 rdf:rest Nec014039794147e3a6b7419613fbfe73
196 Nbc87b700358043e1a5ebe9aa5ecccdae schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
197 schema:name Carcinoma, Hepatocellular
198 rdf:type schema:DefinedTerm
199 Nbd22118a08214c1bba02acfd39a0907e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
200 schema:name Phenylurea Compounds
201 rdf:type schema:DefinedTerm
202 Nc80f18e2d93442829d7b29d4b2bc2826 rdf:first sg:person.0775700471.08
203 rdf:rest rdf:nil
204 Nca7b960b33aa4c87a903fe2142c77372 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
205 schema:name Proteinuria
206 rdf:type schema:DefinedTerm
207 Nca9ab37675e640b4b49fd0e9a8515655 rdf:first sg:person.01335140136.50
208 rdf:rest Nc80f18e2d93442829d7b29d4b2bc2826
209 Ncfdac9585d344b1b84087a37e09e7f97 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
210 schema:name Female
211 rdf:type schema:DefinedTerm
212 Ne6e74a090fd242129b5c8180dd7242fb schema:name doi
213 schema:value 10.1007/s12072-019-09929-4
214 rdf:type schema:PropertyValue
215 Nec014039794147e3a6b7419613fbfe73 rdf:first sg:person.016524357123.11
216 rdf:rest Nca9ab37675e640b4b49fd0e9a8515655
217 Necb9a178682640f29d8d26ea610a8eb7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
218 schema:name Quinolines
219 rdf:type schema:DefinedTerm
220 Nffc49964e6904c8db5820e02646e5df8 rdf:first sg:person.0667017261.48
221 rdf:rest Na74642850fb14b4fbb33c70d60753342
222 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
223 schema:name Medical and Health Sciences
224 rdf:type schema:DefinedTerm
225 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
226 schema:name Clinical Sciences
227 rdf:type schema:DefinedTerm
228 sg:journal.1038556 schema:issn 1936-0533
229 1936-0541
230 schema:name Hepatology International
231 schema:publisher Springer Nature
232 rdf:type schema:Periodical
233 sg:person.011676455302.10 schema:affiliation grid-institutes:grid.419521.a
234 schema:familyName Sato
235 schema:givenName Shinpei
236 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011676455302.10
237 rdf:type schema:Person
238 sg:person.01176700500.71 schema:affiliation grid-institutes:grid.417333.1
239 schema:familyName Ohyama
240 schema:givenName Hiroshi
241 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01176700500.71
242 rdf:type schema:Person
243 sg:person.01177703152.96 schema:affiliation grid-institutes:grid.417333.1
244 schema:familyName Kojima
245 schema:givenName Yuichiro
246 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01177703152.96
247 rdf:type schema:Person
248 sg:person.01207264125.06 schema:affiliation grid-institutes:grid.419521.a
249 schema:familyName Kondo
250 schema:givenName Yuji
251 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01207264125.06
252 rdf:type schema:Person
253 sg:person.01254432457.23 schema:affiliation grid-institutes:grid.419521.a
254 schema:familyName Obi
255 schema:givenName Shuntaro
256 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01254432457.23
257 rdf:type schema:Person
258 sg:person.01335140136.50 schema:affiliation grid-institutes:grid.417333.1
259 schema:familyName Mochizuki
260 schema:givenName Hitoshi
261 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01335140136.50
262 rdf:type schema:Person
263 sg:person.014250513254.95 schema:affiliation grid-institutes:grid.417333.1
264 schema:familyName Ashizawa
265 schema:givenName Hiroshi
266 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014250513254.95
267 rdf:type schema:Person
268 sg:person.015046073654.54 schema:affiliation grid-institutes:grid.417333.1
269 schema:familyName Nakagomi
270 schema:givenName Keiko
271 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015046073654.54
272 rdf:type schema:Person
273 sg:person.015073732504.68 schema:affiliation grid-institutes:grid.417333.1
274 schema:familyName Suzuki
275 schema:givenName Yoji
276 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015073732504.68
277 rdf:type schema:Person
278 sg:person.015131416123.15 schema:affiliation grid-institutes:grid.417333.1
279 schema:familyName Miura
280 schema:givenName Yuko
281 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015131416123.15
282 rdf:type schema:Person
283 sg:person.016524357123.11 schema:affiliation grid-institutes:grid.417333.1
284 schema:familyName Amano
285 schema:givenName Hiroyuki
286 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016524357123.11
287 rdf:type schema:Person
288 sg:person.0632777552.91 schema:affiliation grid-institutes:grid.417333.1
289 schema:familyName Hosoda
290 schema:givenName Kenji
291 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0632777552.91
292 rdf:type schema:Person
293 sg:person.0667017261.48 schema:affiliation grid-institutes:grid.264706.1
294 schema:familyName Sato
295 schema:givenName Takahisa
296 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0667017261.48
297 rdf:type schema:Person
298 sg:person.0705653172.09 schema:affiliation grid-institutes:grid.419521.a
299 schema:familyName Kawai
300 schema:givenName Toshihiro
301 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0705653172.09
302 rdf:type schema:Person
303 sg:person.0760341765.13 schema:affiliation grid-institutes:grid.419521.a
304 schema:familyName Isomura
305 schema:givenName Yoshihiro
306 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0760341765.13
307 rdf:type schema:Person
308 sg:person.0774752554.50 schema:affiliation grid-institutes:grid.419521.a
309 schema:familyName Kanda
310 schema:givenName Miho
311 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0774752554.50
312 rdf:type schema:Person
313 sg:person.0775700471.08 schema:affiliation grid-institutes:grid.26999.3d
314 schema:familyName Omata
315 schema:givenName Masao
316 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0775700471.08
317 rdf:type schema:Person
318 sg:pub.10.1007/s00535-016-1263-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022330529
319 https://doi.org/10.1007/s00535-016-1263-4
320 rdf:type schema:CreativeWork
321 sg:pub.10.1007/s12072-017-9799-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1086045643
322 https://doi.org/10.1007/s12072-017-9799-9
323 rdf:type schema:CreativeWork
324 sg:pub.10.1038/bjc.2012.154 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031103423
325 https://doi.org/10.1038/bjc.2012.154
326 rdf:type schema:CreativeWork
327 grid-institutes:grid.264706.1 schema:alternateName Internal Medicine, Chiba General Medical Center, Teikyo University, 3426-3 Anesaki, 299-0111, Ichihara, Chiba, Japan
328 schema:name Internal Medicine, Chiba General Medical Center, Teikyo University, 3426-3 Anesaki, 299-0111, Ichihara, Chiba, Japan
329 rdf:type schema:Organization
330 grid-institutes:grid.26999.3d schema:alternateName Department of Gastroenterology, Tokyo University, 7-3-1 Hongo, Bunkyo, 113-8655, Tokyo, Japan
331 schema:name Department of Gastroenterology, Tokyo University, 7-3-1 Hongo, Bunkyo, 113-8655, Tokyo, Japan
332 Department of Gastroenterology, Yamanashi Prefectural Central Hospital, 1-1-1 Fujimi, 400-8506, Kofu, Yamanashi, Japan
333 rdf:type schema:Organization
334 grid-institutes:grid.417333.1 schema:alternateName Department of Gastroenterology, Yamanashi Prefectural Central Hospital, 1-1-1 Fujimi, 400-8506, Kofu, Yamanashi, Japan
335 schema:name Department of Gastroenterology, Yamanashi Prefectural Central Hospital, 1-1-1 Fujimi, 400-8506, Kofu, Yamanashi, Japan
336 rdf:type schema:Organization
337 grid-institutes:grid.419521.a schema:alternateName Department of Gastroenterology and Hepatology, Kyoundo Hospital of Sasaki Institute, 1-8 Kandasurugadai, Chiyoda, 101-0062, Tokyo, Japan
338 Department of Pharmacy, Kyoundo Hospital of Sasaki Institute, 1-8 Kandasurugadai, Chiyoda, 101-0062, Tokyo, Japan
339 schema:name Department of Gastroenterology and Hepatology, Kyoundo Hospital of Sasaki Institute, 1-8 Kandasurugadai, Chiyoda, 101-0062, Tokyo, Japan
340 Department of Gastroenterology, Yamanashi Prefectural Central Hospital, 1-1-1 Fujimi, 400-8506, Kofu, Yamanashi, Japan
341 Department of Pharmacy, Kyoundo Hospital of Sasaki Institute, 1-8 Kandasurugadai, Chiyoda, 101-0062, Tokyo, Japan
342 Internal Medicine, Chiba General Medical Center, Teikyo University, 3426-3 Anesaki, 299-0111, Ichihara, Chiba, Japan
343 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...